%TTD and %TUDD: New SAS macro programs to calculate the survival data of the time to deterioration for patient-reported outcomes data in oncology

Autor: Charton, E., Falcoz, A., François, E., Touraine, C., Bachet, J.-B., Louvet, C., Hamidou, Z., Bascoul-Mollevi, C., Anota, A.

Publikováno v: In Computer Methods and Programs in Biomedicine February 2022 214

Longitudinal health-related quality of life analysis in oncology with time to event approaches, the STATA command qlqc30_TTD

Autor: Bascoul-Mollevi, C., Savina, Marion, Anota, Amélie, Barbieri, Antoine, Azria, David, Bonnetain, Franck, Gourgou, Sophie

Publikováno v: In Computer Methods and Programs in Biomedicine May 2018 158:153-159

SAE: An R package for early stopping rules in clinical trials

Autor: Bascoul-Mollevi, C., Laplanche, A., Le Deley, M.C., Kramar, A.

Publikováno v: In Computer Methods and Programs in Biomedicine 2011 104(2):243-248

Qual Life Res

Autor: Bascoul-Mollevi, C., Barbieri, Antoine, Bourgier, C., Conroy, T., Chauffert, B., Hebbar, M., Jacot, W., Juzyna, B., de Forges, H., Gourgou, S., Bonnetain, F., Touraine, C., Anota, A.

Publikováno v: Quality of Life Research
Quality of Life Research, Springer Verlag, 2021, 30 (1), pp.91-103. ⟨10.1007/s11136-020-02605-3⟩

International audience; PURPOSE: Health-related quality of life (HRQoL) is assessed by self-administered questionnaires throughout the care process. Classically, two longitudinal statistical approaches were mainly used to study HRQoL: linear mixed mo

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=od______1398::529a8008ab3e261c18acc8797a4424c0
https://hal.archives-ouvertes.fr/hal-03154718

Comput Methods Programs Biomed

Autor: Bascoul-Mollevi, C., Savina, M., Anota, A., Barbieri, Antoine, Azria, D., Bonnetain, F., Gourgou, S.

Publikováno v: Computer Methods and Programs in Biomedicine
Computer Methods and Programs in Biomedicine, Elsevier, In press, 158, pp.153-159. ⟨10.1016/j.cmpb.2018.02.010⟩

BACKGROUND AND OBJECTIVE: Health-related quality of life (HRQoL) has become one relevant and available alternative endpoint of clinical trials in cancer research to evaluate efficiency of care both for the patient and health system. HRQoL in oncology

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::03e2977c406a7b629cc682d5b4d8910d
https://hal.archives-ouvertes.fr/hal-02971232